FIFOX
Price
$24.86
Change
-$0.15 (-0.60%)
Updated
Dec 17 closing price
GFACX
Price
$73.13
Change
-$0.36 (-0.49%)
Updated
Dec 17 closing price
Ad is loading...

FIFOX vs GFACX

Header iconFIFOX vs GFACX Comparison
Open Charts FIFOX vs GFACXBanner chart's image
Fidelity Advisor Founders A
Price$24.86
Change-$0.15 (-0.60%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$73.13
Change-$0.36 (-0.49%)
VolumeN/A
CapitalizationN/A
FIFOX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIFOX vs. GFACX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIFOX is a StrongBuy and GFACX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 315B vs. FIFOX (181M). FIFOX (0.00) and GFACX (0.00) have matching dividends . FIFOX was incepted earlier than GFACX: FIFOX (6 years) vs GFACX (24 years). FIFOX is a more actively managed with annual turnover of: 51.00 vs. GFACX (31.00). FIFOX has a lower initial minimum investment than GFACX: FIFOX (0) vs GFACX (250). FIFOX annual gain was more profitable for investors over the last year : 37.88 vs. GFACX (34.28). FIFOX return over 5 years is better than : 118.06 vs. GFACX (47.11).
FIFOXGFACXFIFOX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years24 years-
Gain YTD37.19632.964113%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets181M315B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year37.8834.28110%
Returns for 3 years36.3414.71247%
Returns for 5 years118.0647.11251%
Returns for 10 yearsN/A79.77-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADCT2.130.13
+6.50%
ADC Therapeutics SA
NRXS2.570.06
+2.39%
Neuraxis
WEN17.060.17
+1.01%
Wendy's Company
LDOS150.14-2.36
-1.55%
Leidos Holdings
REPL11.72-0.76
-6.09%
Replimune Group